期刊文献+

眼睑皮肤恶性黑色素瘤早期检测进展 被引量:6

The advances on early detection of eyelid malignant melanoma
下载PDF
导出
摘要 眼睑皮肤恶黑瘤发病率低,预后差,在临床及病理上很难与其他肿瘤鉴别。本文回顾了国内外眼睑皮肤恶黑瘤相关基因、肿瘤标志物的文献,发现B-RAF、hTERT、NOS及melan-A均与眼睑皮肤恶性黑色素瘤发生、发展,早期检测相关,有利其鉴别诊断。 Eyelid malignant melanoma is rare but has a grave prognosis. It is very difficult to differentiate eyelid malignant melanoma and other tumors in clinical and pathological. Studies on the correlated genes, tumor markers in eyelid maligo nant melanomas are reviewed in the present paper. The reluits show B-RAF, hTERT, NOS and melan-A contributed to the eyelid malignant melanomas in onset, progress and early detection which are advantageous for differential diagnosis.
作者 张帆 吴晓梅
出处 《国际眼科杂志》 CAS 2007年第2期493-495,共3页 International Eye Science
关键词 眼睑 恶性黑色素瘤 基因 早期检测 eyelid malignant melanoma gene early detection
  • 相关文献

参考文献27

  • 1尹香利,张国昌.BRAF原癌基因与甲状腺癌关系的研究进展[J].陕西医学杂志,2006,35(3):324-327. 被引量:3
  • 2Collisson EA,De A,Suzuki H,Gambhir SS,Kolodney MS.Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade.Cancer Research,2003;63(18):5669-5673
  • 3SmallPv KS.A pivotal role for ERK in malignant melanonla.Int J Cancer,2003;104(5):527-532
  • 4Wellbrock C,Ogilvie L,Hedley D,Kamsarides M,Martin J,Niculescu-Duvaz D,Springer CJ.Marais R.V599EB-RAF is an oncogene in melanocytes.Cancer Research,2004:64(7):2338-2342
  • 5van Dijk MC,Bernsen MR,Ruiter DJ.Analysis of Mutations in B-RAF,N-RAS,and H-RAS Genes in the Differential Diagnosis of Spitz Nevus and Spitzoid Melanoma.Am J Surgical Pathology,2005;29(9):1145-1151
  • 6Uribe P,Wistuba Ⅱ,Gonzalez S.BRAF Mutation:A Frequent Event in Benign,Atypical,and Malignant Melanoeytic Lesions of the Skin.Am J Dermatopathology,2003;25(5):365-370
  • 7孟秀娟.端粒酶在肿瘤疾病中的表达及研究进展[J].河北医药,2003,25(4):305-306. 被引量:3
  • 8Wu A,Ichihashi M.Ueda M.Correlation of the expression of human telomerase subunits with telomerase activity in nomal skin and skin tumors.Cancer,1999;86(10):2038-2044
  • 9Novakovic S,Hocevar M,Zgajnat J,Besic N,Stegel V.Detection of telomerase RNA in the plasma of patients with breast cancer,malignant melanonla or thyroid cancer.Oncology Reports,2004;11(1):245-252
  • 10Miracco C,Pacenti L,Santopietro R,Laurini L,Biagioli M,Luzi P.Evaluation of telomerase activity in cutaneous melanoeytie proliferations.Human Pathology,2000;31(9):1018-1021

二级参考文献95

  • 1何松.介绍一种黑色素瘤特异性抗体(HMB_(-45))在病理诊断中的应用[J].临床与实验病理学杂志,1993,9(3):231-232. 被引量:7
  • 2文忠 肖键云 唐发清 等.鼻咽中癌端粒酶活性的相对定量检测[J].中华医学检验杂志,1999,22:175-175.
  • 3Feng J,Fuck WD, Wang SS,et al. The RNA component of human telomrase.Science, 1995,269:1236.
  • 4Meyerson M, Christopher M. Counter, Elinor. Ng. Eaton, et al. HEST2, the putative human telomerase catalytic Subunit gene, is up-regulation in tumor cells and during immortalizztion.Cell, 1997,90:785-795.
  • 5Yoshdak, Sugino T, Goodison S, et al. Detedion of telomerase activity in exfoliated cancer cells in colonic luminal Washings and its related clinical implication. Br J Cancer, 1997,75:584-593.
  • 6Kavaler E, Iandman J, Chang Y, et al. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer, 1998,82:708-714.
  • 7Counter CM, Cupta J, Harley CB.et al.Telomerase activity in normal leukocytea and in hematologic malignancies. Blood, 1995,85:2315-2320.
  • 8Murakami J,Magei N,Ohana K,et al. Telomerase activity in ovarian tumors.Cancer, 1997,80:1085-1089.
  • 9Loibl S, yon Minckwitz G, Weber S, et al. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy. Cancer, 2002, 95 (6) : 1191 - 1198.
  • 10Goto T, Haruma K, Kitadai Y, et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res, 1999, 5 (6) :1411 -1415.

共引文献11

同被引文献61

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部